Skip to main content
Livermore
Livermore
中文EN

Continuum Advisory, LLC

SEC CIK
0001846532
Latest filing
Aug 6, 2026

The latest 13F from Continuum Advisory, LLC covers Q2 2026 (filed Aug 6, 2026): 1,986 long positions worth $1.24B. The top 10 holdings make up 28.2% of the portfolio, and the largest is Apple Inc. (AAPL) at 3.8%. Livermore has 31 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
1540
Est. +$86.7M
Added
249
Est. +$81.8M
Reduced
172
Est. −$73.4M
Sold out
7
Est. −$13.5M

Top 5 holdings

Share of this quarter's portfolio value

  1. AAPLApple Inc.
    3.8%$47.4MHistory
  2. Capital Group Dividend Value14020W106
    3.7%$46.0M
  3. WMTWalmart Inc.
    3.3%$40.5MHistory
  4. MUMicron Technology Inc
    2.8%$35.2MHistory
  5. J P Morgan Exchange Traded F46641Q670
    2.8%$34.5M

Biggest buys

New and added positions, by estimated amount bought

  1. MCKMcKesson Corp
    +$7.87MAddedHistory
  2. EXEExpand Energy Corp
    +$6.28MNewHistory
  3. INTUIntuit Inc.
    +$5.72MNewHistory
  4. Capital Group New Geography14021N105
    +$4.09MNew
  5. ADBEAdobe Inc.
    +$3.99MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MCKMcKesson Corp
    +0.63 pp<0.1% → 0.7%History
  2. EXEExpand Energy Corp
    +0.51 pp0.0% → 0.5%History
  3. INTUIntuit Inc.
    +0.46 pp0.0% → 0.5%History
  4. Capital Group New Geography14021N105
    +0.33 pp0.0% → 0.3%
  5. ZMZoom Communications, Inc.
    +0.32 pp0.0% → 0.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CVSCVS Health Corp
    −$8.25MReducedHistory
  2. NEMNEWMONT Corp
    −$7.58MReducedHistory
  3. NBIXNeurocrine Biosciences Inc
    −$7.36MReducedHistory
  4. EGEverest Group, Ltd.
    −$6.18MReducedHistory
  5. ULTAUlta Beauty, Inc.
    −$6.07MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. NEMNEWMONT Corp
    −0.85 pp0.9% → <0.1%History
  2. ULTAUlta Beauty, Inc.
    −0.58 pp0.6% → 0.0%History
  3. NBIXNeurocrine Biosciences Inc
    −0.55 pp0.6% → <0.1%History
  4. CVSCVS Health Corp
    −0.55 pp0.6% → <0.1%History
  5. EGEverest Group, Ltd.
    −0.54 pp0.5% → <0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.24B
+$194.1M (+18.6%) vs. prior quarter
Positions
1,986
+1,533 vs. prior quarter
Top 10 concentration
28.2%
Top 10 as share of value
Turnover
7.6%
Q2 2026, one quarter
Average holding period
16.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.24B (Q2 2026)

Q1 2021: $240.1MQ2 2021: $321.7MQ3 2021: $373.2MQ4 2021: $444.6MQ1 2022: $526.4MQ2 2022: $548.8MQ3 2022: $565.7MQ4 2022: $554.2MQ1 2023: $589.2MQ2 2023: $628.7MQ3 2023: $624.0MQ4 2023: $702.9MQ1 2024: $667.9MQ2 2024: $693.8MQ3 2024: $783.2MQ4 2024: $780.0MQ1 2025: $776.4MQ2 2025: $830.7MQ3 2025: $946.0MQ4 2025: $998.6MQ1 2026: $1.04BQ2 2026: $1.24B
Q1 2021Q2 2026
13F filings of Continuum Advisory, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 6, 20261,986$1.24BAAPLCapital Group Dividend ValueWMTvs. Q1 2026SEC
Q1 2026Apr 22, 2026453$1.04BWMTAAPLCapital Group Dividend Valuevs. Q4 2025SEC
Q4 2025Feb 11, 2026456$998.6MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q3 2025SEC
Q3 2025Oct 20, 2025437$946.0MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q2 2025SEC
Q2 2025Aug 13, 2025420$830.7MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q1 2025SEC
Q1 2025Apr 23, 20251,657$776.4MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q4 2024SEC
Q4 2024Feb 18, 20251,852$780.0MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q3 2024SEC
Q3 2024Nov 15, 20241,911$783.2MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q2 2024SEC
Q2 2024Jul 19, 20241,704$693.8MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q1 2024SEC
Q1 2024May 13, 20241,698$667.9MCapital Group Dividend ValueAAPLJ P Morgan Exchange Traded Fvs. Q4 2023SEC
Q4 2023Feb 14, 2024451$702.9MAAPLCapital Group Dividend ValueVanguard Morningstar Total Stock Market ETFvs. Q3 2023SEC
Q3 2023Nov 13, 2023449$624.0MAAPLSsga Active ETF TrMSFTvs. Q2 2023SEC
Q2 2023Dec 13, 2023Amended446$628.7MAAPLSsga Active ETF TrMSFTvs. Q1 2023SEC
Q1 2023Dec 13, 2023Amended422$589.2MAAPLSsga Active ETF TrMSFTvs. Q4 2022SEC
Q4 2022Dec 13, 2023Amended410$554.2MAAPLSsga Active ETF TrMSFTvs. Q3 2022SEC
Q3 2022Dec 13, 2023Amended403$565.7MAAPLSPDR Series TrustSsga Active ETF Trvs. Q2 2022SEC
Q2 2022Dec 13, 2023Amended401$548.8MSPDR Series TrustAAPLMSFTvs. Q1 2022SEC
Q1 2022Dec 13, 2023Amended374$526.4MAAPLSPDR Series TrustVanguard Index FDSvs. Q4 2021SEC
Q4 2021Dec 13, 2023Amended302$444.6MAAPLSPDR Series TrustVanguard Index FDSvs. Q3 2021SEC
Q3 2021Dec 13, 2023Amended294$373.2MAAPLSPDR Series TrustVanguard Index FDSvs. Q2 2021SEC
Q2 2021Dec 13, 2023Amended269$321.7MAAPLSPDR Series TrustVanguard Index FDSvs. Q1 2021SEC
Q1 2021May 14, 2021171$240.1MAAPLSPDR Series TrustVanguard Index FDS–SEC